BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20044871)

  • 1. The association of patient-physician gender concordance with cardiovascular disease risk factor control and treatment in diabetes.
    Schmittdiel JA; Traylor A; Uratsu CS; Mangione CM; Ferrara A; Subramanian U
    J Womens Health (Larchmt); 2009 Dec; 18(12):2065-70. PubMed ID: 20044871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.
    Schmittdiel JA; Uratsu CS; Karter AJ; Heisler M; Subramanian U; Mangione CM; Selby JV
    J Gen Intern Med; 2008 May; 23(5):588-94. PubMed ID: 18317847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient race/ethnicity and patient-physician race/ethnicity concordance in the management of cardiovascular disease risk factors for patients with diabetes.
    Traylor AH; Subramanian U; Uratsu CS; Mangione CM; Selby JV; Schmittdiel JA
    Diabetes Care; 2010 Mar; 33(3):520-5. PubMed ID: 20009094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
    Yu J; Shah BM; Ip EJ; Chan J
    J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in cardiovascular disease risk factor management in primary care by sex of physician and patient.
    Tabenkin H; Eaton CB; Roberts MB; Parker DR; McMurray JH; Borkan J
    Ann Fam Med; 2010; 8(1):25-32. PubMed ID: 20065275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter?
    Traylor AH; Schmittdiel JA; Uratsu CS; Mangione CM; Subramanian U
    J Gen Intern Med; 2010 Nov; 25(11):1172-7. PubMed ID: 20571929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-Related Differences in the Control of Cardiovascular Risk Factors in Primary Care for Elderly Patients With Type 2 Diabetes: A Cohort Study.
    Al-Salameh A; Bucher S; Bauduceau B; Benattar-Zibi L; Berrut G; Bertin P; Corruble E; Danchin N; Derumeaux G; Doucet J; Falissard B; Forette F; Hanon O; Ourabah R; Pasquier F; Pinget M; Ringa V; Becquemont L
    Can J Diabetes; 2018 Aug; 42(4):365-371.e2. PubMed ID: 29037572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment intensification and risk factor control: toward more clinically relevant quality measures.
    Selby JV; Uratsu CS; Fireman B; Schmittdiel JA; Peng T; Rodondi N; Karter AJ; Kerr EA
    Med Care; 2009 Apr; 47(4):395-402. PubMed ID: 19330888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing diabetes care regarding cardiovascular targets at general practice level: Direct@GP.
    Wens J; Gerard R; Vandenberghe H
    Prim Care Diabetes; 2011 Apr; 5(1):19-24. PubMed ID: 21030327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level.
    Roccatagliata D; Avanzini F; Monesi L; Caimi V; Lauri D; Longoni P; Marchioli R; Tombesi M; Tognoni G; Roncaglioni MC;
    Vasc Health Risk Manag; 2006; 2(4):507-14. PubMed ID: 17323606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Patient-Physician Language Concordance and Glycemic Control for Limited-English Proficiency Latinos With Type 2 Diabetes.
    Parker MM; Fernández A; Moffet HH; Grant RW; Torreblanca A; Karter AJ
    JAMA Intern Med; 2017 Mar; 177(3):380-387. PubMed ID: 28114680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physician gender is associated with the quality of type 2 diabetes care.
    Berthold HK; Gouni-Berthold I; Bestehorn KP; Böhm M; Krone W
    J Intern Med; 2008 Oct; 264(4):340-50. PubMed ID: 18397244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Consistently Low Performance to Identify Low-Quality Physician Groups.
    Nguyen CA; Gilstrap LG; Chernew ME; McWilliams JM; Landon BE; Landrum MB
    JAMA Netw Open; 2021 Jul; 4(7):e2117954. PubMed ID: 34319356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of cardiovascular disease care in Ontario, Canada: missed opportunities for prevention - a cross sectional study.
    Liddy C; Singh J; Hogg W; Dahrouge S; Deri-Armstrong C; Russell G; Taljaard M; Akbari A; Wells G
    BMC Cardiovasc Disord; 2012 Sep; 12():74. PubMed ID: 22970753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study.
    Kautzky-Willer A; Stich K; Hintersteiner J; Kautzky A; Kamyar MR; Saukel J; Johnson J; Lemmens-Gruber R
    Cardiovasc Diabetol; 2013 May; 12():78. PubMed ID: 23705959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol: the Adherence and Intensification of Medications (AIM) study--a cluster randomized controlled effectiveness study.
    Heisler M; Hofer TP; Klamerus ML; Schmittdiel J; Selby J; Hogan MM; Bosworth HB; Tremblay A; Kerr EA
    Trials; 2010 Oct; 11():95. PubMed ID: 20939913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving treatment intensification to reduce cardiovascular disease risk: a cluster randomized trial.
    Selby JV; Schmittdiel JA; Fireman B; Jaffe M; Ransom LJ; Dyer W; Uratsu CS; Reed ME; Kerr EA; Hsu J
    BMC Health Serv Res; 2012 Jul; 12():183. PubMed ID: 22747998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial.
    Howard BV; Roman MJ; Devereux RB; Fleg JL; Galloway JM; Henderson JA; Howard WJ; Lee ET; Mete M; Poolaw B; Ratner RE; Russell M; Silverman A; Stylianou M; Umans JG; Wang W; Weir MR; Weissman NJ; Wilson C; Yeh F; Zhu J
    JAMA; 2008 Apr; 299(14):1678-89. PubMed ID: 18398080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicians' gender is associated with risk factor control in patients on antihypertensive and lipid lowering treatment.
    Journath G; Hellénius ML; Carlsson AC; Wändell PE; Nilsson PM;
    Blood Press; 2010 Aug; 19(4):240-8. PubMed ID: 20446878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia.
    Cybulsky M; Cook S; Kontsevaya AV; Vasiljev M; Leon DA
    BMC Cardiovasc Disord; 2016 Jun; 16():122. PubMed ID: 27255373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.